Carey Gallant | Investor Relations, LifeSci Advisors |
Paula Ragan | Chief Executive Officer |
Adam Mostafa | Chief Financial Officer |
Art Taveras | Chief Scientific Officer |
Trevor Allred | Oppenheimer |
RK | H.C. Wainwright |
Zegbeh Jallah | ROTH Capital Partners |
Mayank Mamtani | B. Riley Financial |
Ben Shim | Canaccord. |
Greetings, and welcome to X4 Pharmaceuticals Second Quarter Financial and Operating Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
As a reminder this conference call is being recorded. It is now my pleasure to introduce your host Carey Gallant of LifeSci Advisors.